ATHA (athira.com) Earnings growth in current year

Official company branding of Athira Pharma Corp (ATHA)

The current R&D pipeline of Athira Pharma, Inc. (ATHA) is undergoing a review phase following ambiguous drug test results. An analysis of YoY EPS changes on GURU.Markets highlights profit dynamics, where the 76.00 metric serves as the target stability level. The scaling potential of Alzheimer's therapy provides access to a massive market, while streamlined international biomaterial logistics support high business profitability.

ATHA (athira.com) Earnings per share growth in current year history from 07/04/2022 to 01/12/2026

Financial and market metric breakdowns for athira.com (ATHA)

- stock price and consensus target price:
Basic company analysis:Athira Pharma Corp (ATHA)
Manufactured products of Athira Pharma, Inc.

This metric measures the year-over-year dynamics of earnings per share, reflecting the efficiency of capital generation. Analyzing the annual variation in EPS allows for the determination of the business's fundamental stability during periods of market volatility. It is crucial for investors to correlate this data with price trends to minimize drawdown risks. For Athira Pharma, Inc. (ATHA), such a metric is critical due to the high costs associated with developing Alzheimer's treatments. The current liquidity reserve mitigates the negative impact of R&D expenses on the bottom line.

Main competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year GRCE|AIFF: Earnings per share trend in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|RVPH: Net earnings per share growth this year|Expected net earnings per share growth this year MetaVia MTVA|neuraxis.com (NRXS) - Earnings per share growth in current year|Helius Medical Technologies Inc. - Earnings per share increase in current year|PASG (Passage Bio, Inc.) - Earnings growth in current year|bionomics.com.au - Earnings per share trend in current year|Earnings growth in current year NERV|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE